NCT01778101View on ClinicalTrials.gov

Lansoprazole in Preterm Infants With Reflux

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
Preterm InfantsGastrointestinal Reflux
Interventions
DRUG

Lansoprazole

lansoprazole 1mg/kg twice a day for 14days

Trial Locations (1)

110-740

Seoul National University Children's Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01778101 - Lansoprazole in Preterm Infants With Reflux | Biotech Hunter | Biotech Hunter